Baxter International Inc (BAX) - Total Assets

Latest as of June 2026: $19.79 Billion USD

Based on the latest financial reports, Baxter International Inc (BAX) holds total assets worth $19.79 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Baxter International Inc - Total Assets Trend (1985–2025)

This chart illustrates how Baxter International Inc's total assets have evolved over time, based on quarterly financial data. Also see how much is Baxter International Inc worth for the company's overall valuation and market capitalisation.

Baxter International Inc - Asset Composition Analysis

Current Asset Composition (December 2025)

Baxter International Inc's total assets of $19.79 Billion consist of 34.3% current assets and 65.7% non-current assets. Review Baxter International Inc balance sheet liabilities to assess the company's total debt and financial obligations.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $1.97 Billion 9.8%
Accounts Receivable $1.93 Billion 9.6%
Inventory $2.23 Billion 11.1%
Property, Plant & Equipment $3.19 Billion 15.9%
Intangible Assets $4.37 Billion 21.8%
Goodwill $4.93 Billion 24.6%

Asset Composition Trend (1985–2025)

This chart illustrates how Baxter International Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See current stock price of Baxter International Inc for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Baxter International Inc's current assets represent 34.3% of total assets in 2025, a decrease from 34.6% in 1985.
  • Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, up from 4.0% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 45.0% of total assets, an increase from 34.0% in 1985.
  • Asset Diversification: The largest asset category is goodwill at 24.6% of total assets.

Baxter International Inc Competitors by Total Assets

Key competitors of Baxter International Inc based on total assets are shown below.

Company Country Total Assets
Alcon AG
SW:ALC
Switzerland CHF31.53 Billion
STAAR Surgical Company
NASDAQ:STAA
USA $475.20 Million
BMC Medical Co. Ltd. A
SHE:301367
China CN¥3.38 Billion
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
China CN¥2.06 Billion
Vizionfocus Inc.
TW:4771
Taiwan NT$7.44 Billion
Spineway
PA:ALSPW
France €29.46 Million
Safe Orthopaedics SA
PA:ALSAF
France €11.81 Million
Ansell Ltd
AU:ANN
Australia AU$3.33 Billion

Baxter International Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.95 2.30 2.37
Quick Ratio 1.32 1.49 1.78
Cash Ratio 0.00 0.57 0.95
Working Capital $3.40 Billion $3.81 Billion $4.73 Billion

Baxter International Inc - Advanced Valuation Insights

This section examines the relationship between Baxter International Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.30
Latest Market Cap to Assets Ratio 0.67
Asset Growth Rate (YoY) -22.2%
Total Assets $20.05 Billion
Market Capitalization $13.35 Billion USD

Valuation Analysis

Below Book Valuation: The market values Baxter International Inc's assets below their book value (0.67x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Baxter International Inc's assets decreased by 22.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Baxter International Inc (1985–2025)

The table below shows the annual total assets of Baxter International Inc from 1985 to 2025.

Year Total Assets Change
2025-12-31 $20.05 Billion -22.21%
2024-12-31 $25.78 Billion -8.82%
2023-12-31 $28.28 Billion -0.04%
2022-12-31 $28.29 Billion -15.61%
2021-12-31 $33.52 Billion +67.45%
2020-12-31 $20.02 Billion +10.04%
2019-12-31 $18.19 Billion +15.73%
2018-12-31 $15.72 Billion -8.13%
2017-12-31 $17.11 Billion +10.07%
2016-12-31 $15.55 Billion -25.84%
2015-12-31 $20.96 Billion -19.80%
2014-12-31 $26.14 Billion +3.62%
2013-12-31 $25.22 Billion +23.71%
2012-12-31 $20.39 Billion +6.91%
2011-12-31 $19.07 Billion +9.06%
2010-12-31 $17.49 Billion +0.78%
2009-12-31 $17.35 Billion +12.65%
2008-12-31 $15.40 Billion +0.73%
2007-12-31 $15.29 Billion +4.14%
2006-12-31 $14.69 Billion +15.39%
2005-12-31 $12.73 Billion -10.04%
2004-12-31 $14.15 Billion +3.21%
2003-12-31 $13.71 Billion +9.85%
2002-12-31 $12.48 Billion +20.64%
2001-12-31 $10.34 Billion +18.44%
2000-12-31 $8.73 Billion -9.45%
1999-12-31 $9.64 Billion -2.32%
1998-12-31 $9.87 Billion +13.39%
1997-12-31 $8.71 Billion +14.63%
1996-12-31 $7.60 Billion -19.51%
1995-12-31 $9.44 Billion -5.65%
1994-12-31 $10.00 Billion -5.15%
1993-12-31 $10.54 Billion +15.18%
1992-12-31 $9.15 Billion -1.98%
1991-12-31 $9.34 Billion +9.66%
1990-12-31 $8.52 Billion +0.16%
1989-12-31 $8.50 Billion -0.55%
1988-12-31 $8.55 Billion +11.94%
1987-12-31 $7.64 Billion +8.06%
1986-12-31 $7.07 Billion +3.35%
1985-12-31 $6.84 Billion --

About Baxter International Inc

NYSE:BAX USA Medical Instruments & Supplies
Market Cap
$13.35 Billion
Market Cap Rank
#1801 Global
#688 in USA
Share Price
$25.83
Change (1 day)
+1.02%
52-Week Range
$15.80 - $28.35
All Time High
$85.36
About

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable p… Read more